NCT00171574View on ClinicalTrials.gov

Antiproteinuric Effect of Valsartan and Lisinopril

PHASE4CompletedINTERVENTIONAL
Enrollment

124

Participants

Timeline

Start Date

November 30, 2004

Primary Completion Date

July 31, 2006

Study Completion Date

July 31, 2006

Conditions
HypertensionDiabetic Nephropathy
Interventions
DRUG

Valsartan

DRUG

Valsartan plus HCTZ

DRUG

Lisinopril

Trial Locations (1)

Unknown

Novartis Pharmaceuticals, Basel

Sponsors

Lead Sponsor

Novartis
All Listed Sponsors
lead

Novartis

INDUSTRY

NCT00171574 - Antiproteinuric Effect of Valsartan and Lisinopril | Biotech Hunter | Biotech Hunter